Massachusetts researchers have developed an RNA-based method for the rapid detection of pathogens in clinical samples. The team is now designing an integrated diagnostic platform that contains a comprehensive set of bacterial, viral and fungal probes to help pinpoint specific pathogens and their degree of drug resistance more efficiently than conventional diagnostics.